Laurent Pharma - News and Events

News

Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b in Cystic Fibrosis at the NACFC 2022

3 November 2022

LAU-7b first inflammation-controlling drug to demonstrate clinical benefit in adults with CF, complementary to administration of CFTR modulators.Study achieves clinically meaningful...

Laurent Pharmaceuticals to present at the North American Cystic Fibrosis Conference

4 October 2022

Laurent Pharmaceuticals to present at the North American Cystic Fibrosis Conference, November 3-5, 2022, Philadelphia, PA

EVENTS

Laurent Pharma to participate to BIO International Convention, June 13-16, 2022 – San Diego, CA

Laurent Pharma to participate to BIO-Europe Spring, March 28-31, 2022

Laurent Pharma to participate to BiotechGate, February 7-9, 2022

Laurent Pharma to participate to Biotech Showcase, January 9-11 and 17-19, 2022

Laurent Pharma to participate to H.C. Wainwright 23rd Annual Global Investment Conference,
September 13-15, 2021